missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ Omipalisib

Description
Omipalisib is a highly potent PI 3-K inhibitor (IC50 = 0.04 nM). Also inhibits mTOR (Ki = 0.18 - 0.3 nM) and DNA-PK (IC50 = 0.28 nM). Induces G1 cell cycle arrest and inhibits proliferation of some breast cancer cells lines in vitro. Reduces pAKT-S473 levels in and inhibits growth of BT474 breast cancer xenografts in mice. Orally bioavailable.
Specifications
Specifications
| Chemical Name or Material | 2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide |
| Synonym | GSK2126458 |
| Quantity | 10 mg |
| Molecular Formula | C25H17F2N5O3S |
| Formula Weight | 505.5 |
| Product Type | Inhibitor |
| Purity | 98% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?